Found: 139
Select item for more details and to access through your institution.
Comparison of Drug-Free Remission after the End of Phase III Trials of Three Different Anti-IL-23 Inhibitors in Psoriasis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2607, doi. 10.1007/s13555-024-01229-6
- By:
- Publication type:
- Article
Response of superimposed linear psoriasis to ustekinumab: A case report.
- Published in:
- 2017
- By:
- Publication type:
- case study
A solitary facial tumor with erosion on an 81-year-old oriental woman. Atypical fibroxanthoma.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Characteristics of psoriatic plaques in generalized pustular psoriasis patients with or without IL36RN mutation.
- Published in:
- 2024
- By:
- Publication type:
- Letter
The impact of long-term secukinumab treatment on Epstein-Barr virus and cytomegalovirus loads in patients with psoriasis.
- Published in:
- International Journal of Dermatology, 2016, v. 55, n. 11, p. e600, doi. 10.1111/ijd.13346
- By:
- Publication type:
- Article
Herpes zoster-associated severity and duration of pain, health-related quality of life, and healthcare utilization in Taiwan: a prospective observational study.
- Published in:
- International Journal of Dermatology, 2015, v. 54, n. 5, p. 529, doi. 10.1111/ijd.12484
- By:
- Publication type:
- Article
Etanercept use for psoriasis in Taiwan: a case series study.
- Published in:
- International Journal of Dermatology, 2013, v. 52, n. 6, p. 673, doi. 10.1111/j.1365-4632.2011.05273.x
- By:
- Publication type:
- Article
Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 10, p. 915, doi. 10.1007/s40261-020-00956-w
- By:
- Publication type:
- Article
Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 12, p. 1195, doi. 10.1007/s40261-019-00849-7
- By:
- Publication type:
- Article
Human leukocyte antigen and demographic characteristics in Chinese patients with active peripheral type psoriatic arthritis who had inadequate response to conventional disease-modifying antirheumatic drugs in a single dermatologic clinic.
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0210076
- By:
- Publication type:
- Article
Associations between HLA-Cw1 and Systemic Treatment Response of Asian Psoriasis Patients.
- Published in:
- Molecular Diagnosis & Therapy, 2022, v. 26, n. 5, p. 541, doi. 10.1007/s40291-022-00603-4
- By:
- Publication type:
- Article
Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic.
- Published in:
- Molecular Diagnosis & Therapy, 2020, v. 24, n. 1, p. 85, doi. 10.1007/s40291-019-00441-x
- By:
- Publication type:
- Article
Acquired diffuse palmoplantar erythema with keratoderma in Chinese patients with pustular psoriasis: A predictor for IL36 receptor antagonist c.115+6T>C mutation?
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 3, p. 1, doi. 10.1111/exd.15056
- By:
- Publication type:
- Article
Predictors for the effectiveness of 75 mg risankizumab in treating psoriasis—A real‐word evidence from a 52‐week retrospective study.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 12, p. 2138, doi. 10.1111/exd.14963
- By:
- Publication type:
- Article
Deficiency of interleukin‐36 receptor antagonist (DITRA): An analysis of 58 Chinese patients in a tertiary hospital in Taiwan.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 8, p. 1272, doi. 10.1111/exd.14783
- By:
- Publication type:
- Article
Effectiveness and safety of reduced‐dose secukinumab switching to risankizumab for psoriasis patients in Asian population: A case series.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
HLA-DRB1*0701 and DRB1*1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population.
- Published in:
- British Journal of Dermatology, 1998, v. 139, n. 6, p. 978, doi. 10.1046/j.1365-2133.1998.02552.x
- By:
- Publication type:
- Article
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2.
- Published in:
- Rheumatology, 2018, v. 57, n. 11, p. 2001, doi. 10.1093/rheumatology/key182
- By:
- Publication type:
- Article
Estimating the burden of genital warts in Taiwan.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Pressurized Skin: A Review on the Pathological Effect of Mechanical Pressure on the Skin from the Cellular Perspective.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 20, p. 15207, doi. 10.3390/ijms242015207
- By:
- Publication type:
- Article
Overlapping Features of Psoriasis and Atopic Dermatitis: From Genetics to Immunopathogenesis to Phenotypes.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 10, p. 5518, doi. 10.3390/ijms23105518
- By:
- Publication type:
- Article
Drug- or Vaccine-Induced/Aggravated Psoriatic Arthritis: A Systematic Review.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 59, doi. 10.1007/s13555-023-01082-z
- By:
- Publication type:
- Article
Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3097, doi. 10.1007/s13555-023-01037-4
- By:
- Publication type:
- Article
Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3181, doi. 10.1007/s13555-023-01033-8
- By:
- Publication type:
- Article
Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 11, p. 2721, doi. 10.1007/s13555-023-01026-7
- By:
- Publication type:
- Article
Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2).
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 891, doi. 10.1007/s13555-023-00903-5
- By:
- Publication type:
- Article
Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2).
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 1, p. 315, doi. 10.1007/s13555-022-00861-4
- By:
- Publication type:
- Article
Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 1, p. 347, doi. 10.1007/s13555-022-00835-6
- By:
- Publication type:
- Article
Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 11, p. 2415, doi. 10.1007/s13555-022-00818-7
- By:
- Publication type:
- Article
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 4, p. 835, doi. 10.1007/s13555-022-00713-1
- By:
- Publication type:
- Article
Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 511, doi. 10.1007/s13555-021-00675-w
- By:
- Publication type:
- Article
Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 3, p. 719, doi. 10.1007/s13555-021-00524-w
- By:
- Publication type:
- Article
Predictive Value of NUDT15 Variants on Neutropenia Among Han Chinese Patients with Dermatologic Diseases: A Single-Center Observational Study.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 2, p. 263, doi. 10.1007/s13555-020-00360-4
- By:
- Publication type:
- Article
Remission Duration and Long-Term Outcomes in Patients with Moderate-to-Severe Psoriasis Treated by Biologics or Tofacitinib in Controlled Clinical Trials: A 15-Year Single-Center Experience.
- Published in:
- Dermatology & Therapy, 2019, v. 9, n. 3, p. 553, doi. 10.1007/s13555-019-0310-5
- By:
- Publication type:
- Article
Itraconazole in the Treatment of Nonfungal Cutaneous Diseases: A Review.
- Published in:
- Dermatology & Therapy, 2019, v. 9, n. 2, p. 271, doi. 10.1007/s13555-019-0299-9
- By:
- Publication type:
- Article
Facial erythema during dupilumab treatment for atopic dermatitis successfully remedied with topical crisaborole ointment: A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15843
- By:
- Publication type:
- Article
Botulinum toxin type A injection in the treatment of acquired symmetrical acrokeratoderma: One case report.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14442
- By:
- Publication type:
- Article
Kyrle's disease successfully treated with allopurinol.
- Published in:
- International Journal of Dermatology, 2011, v. 50, n. 9, p. 1170, doi. 10.1111/j.1365-4632.2009.04454.x
- By:
- Publication type:
- Article
Pharmacological Management of Pediatric Pustular Psoriasis.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 3, p. 265, doi. 10.1007/s40272-020-00383-6
- By:
- Publication type:
- Article
The Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score: online assessment and validation study of a specific measure of GPP disease activity.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 1, p. 138, doi. 10.1093/bjd/ljad071
- By:
- Publication type:
- Article
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 2, p. 198, doi. 10.1093/bjd/ljac040
- By:
- Publication type:
- Article
Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO).
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2023, v. 16, p. 2971, doi. 10.2147/CCID.S426972
- By:
- Publication type:
- Article
Pressure and Skin: A Review of Disease Entities Driven or Influenced by Mechanical Pressure.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 2, p. 261, doi. 10.1007/s40257-023-00833-0
- By:
- Publication type:
- Article
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 6, p. 869, doi. 10.1007/s40257-022-00719-7
- By:
- Publication type:
- Article
HLA-Cw1 and Psoriasis.
- Published in:
- American Journal of Clinical Dermatology, 2021, v. 22, n. 3, p. 339, doi. 10.1007/s40257-020-00585-1
- By:
- Publication type:
- Article
Managing Scalp Psoriasis: An Evidence-Based Review.
- Published in:
- American Journal of Clinical Dermatology, 2017, v. 18, n. 1, p. 17, doi. 10.1007/s40257-016-0222-4
- By:
- Publication type:
- Article
Prevalence, clinical features and treatment pattern of patients with concurrent diagnoses of rheumatoid arthritis and psoriatic disease: results of a 14-year retrospective study in a tertiary referral center.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319847900
- By:
- Publication type:
- Article
Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319843756
- By:
- Publication type:
- Article
Prevalence, clinical features and treatment pattern of patients with concurrent diagnoses of rheumatoid arthritis and psoriatic disease: results of a 14-year retrospective study in a tertiary referral center.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319847900
- By:
- Publication type:
- Article